HRT Financial’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

HRT Financial’s Portfolio GLS.WS Stock Details GLS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,546	Closed	–	–	3609
2022 Q4	$0	Sell	18,546 -48,618	-72%	-$963	﹤0.01%	3600
2022 Q3	$3K	Sell	67,164 -5,460	-8%	-$430	﹤0.01%	2642
2022 Q2	$7K	Sell	72,624 -1,603	-2%	-$376	﹤0.01%	2719
2022 Q1	$16K	Buy	+74,227	New	+$17.4K	﹤0.01%	2861

Other funds holding GLS.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

HRT Financial's GLS.WS Position: Q1 2023 in Review

HRT Financial sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 18,546 shares.

HRT Financial first reported a position in GLS.WS in Q1 2022 and held it in 4 quarters. The position peaked at $16K in Q1 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

HRT Financial reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 18,546 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023.
HRT Financial first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
HRT Financial's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $16K in Q1 2022.
4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.